Table 1.
Demographic and Disease Details of All Patients Enrolled in the Clinical Trial
| Variables | N = 13, n (%) |
|---|---|
| Age, median (range) | 63 y (52–75) |
| Sex | |
| Female | 6 (46) |
| Male | 7 (54) |
| Race | |
| Asian | 1 (8) |
| White | 11 (85) |
| Not specified | 1 (8) |
| Histologic diagnosis | |
| Adenosquamous | 2 (17) |
| Squamous | 10 (83) |
| Unknown | 1 (8) |
| Stage | |
| IIIB | 1 (8) |
| IV | 11 (92) |
| ECOG PS | |
| 0 | 2 (15) |
| 1 | 11 (85) |
| Previous lines of trt | |
| 1 | 5 (42) |
| 2 | 4 (33) |
| ≥3 | 3 (25) |
| Previous nonbrain XRT | |
| No | 3 (25) |
| Yes | 9 (75) |
| Previous brain XRT for NSCLC | |
| No | 10 (83) |
| Yes | 2 (17) |
| Previous surgery for NSCLC | |
| No | 6 (50) |
| Yes | 6 (50) |
ECOG, Eastern Cooperative Oncology Group; PS, performance status; trt, treatment; XRT, radiotherapy.